Calidi Biotherapeutics, Inc. - CLDI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2026 · Q2 2026
Value (USD)
Total reported value ($000)
$75K
QoQ value delta ($000)
-$8K (-9.64%)
Implied price effect (QoQ)
+0.54%
Shares
Total shares
472,356
QoQ shares delta
-53,190 (-10.12%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CLDI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2026)

Top 25 only Full list
Partial Q3 2026 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
GEODE CAPITAL MANAGEMENT, LLC 19 114,550 0.0%
HighTower Advisors, LLC 14 83,523 0.0%
JANE STREET GROUP, LLC 9 54,274 0.0%
Independent Advisor Alliance 7 45,000 0.0%
Arax Advisory Partners 6 37,345 0.0%
Private Advisor Group, LLC 5 30,000 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 4 25,509 0.0%
NORTHERN TRUST CORP 3 17,758 0.0%
Belpointe Asset Management LLC 3 19,921 0.0%
MORGAN STANLEY 2 13,244 0.0%
RFG Advisory, LLC 2 12,000 0.0%
UBS Group AG 1 7,882 0.0%
CITIGROUP INC 0 4,594 0.0%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 0 1,042 0.0%
EVERMAY WEALTH MANAGEMENT LLC 0 1 0.0%
Tower Research Capital LLC (TRC) 0 1,396 0.0%
Finepoint Capital LP 0 1,042 0.0%
OSAIC HOLDINGS, INC. 0 2,650 0.0%
Farther Finance Advisors, LLC 0 625 0.0%